# PrimaNova Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/primanova-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.primanovamed.com
- Latest round: Series B (Sep 15, 2025)
- Investors on record: 3

## About

Based in Shenzhen, China, and founded in 2020, PrimaNova Technologies operates as a neurological disease solution provider, specializing in medical devices for neurosurgery. The company has established R&D centers in the US and Europe. It has cooperated with Healthcare Capital Partners and TheraNova Medical Device Innovation. Its wireless intracranial multiparameter monitoring system completes clinical trials. In April 2024, PrimaNova Technologies closed a series A funding.

PrimaNova Technologies has built product pipelines that focus on neuromonitoring systems, cerebrospinal fluid management systems, intraoperative devices, and surgical robots. Its main product is the wireless intracranial multiparameter monitoring system Sencere, which is capable of real-time continuous monitoring of ICP, ICT, IBP, CPP and other parameters.

The company generates revenue by offering neuromonitoring systems, cerebrospinal fluid management systems, intraoperative instruments, and surgical robots.

## Funding rounds

- Series B, Sep 15, 2025 — JIF Capital
- Series A, Apr 29, 2024 — Shanghai Healthcare Capital, Langyao Capital

## Investors

- Shanghai Healthcare Capital (https://capitalatlas.ai/funds/shanghai-healthcare-capital) — Series A
- Langyao Capital — Series A
- JIF Capital (https://capitalatlas.ai/funds/jif-capital) — Series B